STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 7, Pages e002852
Publisher
BMJ
Online
2021-07-03
DOI
10.1136/jitc-2021-002852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distribution of BCG-CWS loaded nanoparticles in the spleen after intravenous injection affects cytotoxic T lymphocyte activity
- (2020) Hideyuki Masuda et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Poor outcome with anti-programmed death-ligand 1 (PD-L1) antibody due to poor pharmacokinetic properties in PD-1/PD-L1 blockade-sensitive mouse models
- (2020) Taiki Kurino et al. Journal for ImmunoTherapy of Cancer
- NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
- (2020) Christopher J. Nicolai et al. Science Immunology
- Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
- (2020) Daniel Shae et al. ACS Nano
- Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
- (2019) Daniel Shae et al. Nature Nanotechnology
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- STING Polymer Structure Reveals Mechanisms for Activation, Hyperactivation, and Inhibition
- (2019) Sabrina L. Ergun et al. CELL
- STING induces early IFN-β in the liver and constrains myeloid cell-mediated dissemination of murine cytomegalovirus
- (2019) Pia-Katharina Tegtmeyer et al. Nature Communications
- SLC19A1 transports immunoreactive cyclic dinucleotides
- (2019) Rutger D. Luteijn et al. NATURE
- The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma
- (2019) Martin K. Thomsen et al. ONCOGENE
- An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
- (2019) Yang Liu et al. Nature Communications
- The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy
- (2019) Rikito Endo et al. Scientific Reports
- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses
- (2018) Natalia Aptsiauri et al. CURRENT OPINION IN IMMUNOLOGY
- Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core
- (2018) Takashi Nakamura et al. MOLECULAR PHARMACEUTICS
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
- (2018) Joy Hsu et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response
- (2018) Assaf Marcus et al. IMMUNITY
- PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
- (2018) Dmitriy Zamarin et al. JOURNAL OF CLINICAL INVESTIGATION
- Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology
- (2018) Hideyuki Masuda et al. MOLECULAR PHARMACEUTICS
- Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
- (2018) Yong Liang et al. Nature Communications
- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A STING-activating nanovaccine for cancer immunotherapy
- (2017) Min Luo et al. Nature Nanotechnology
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- In vivo imaging reveals a tumor-associated macrophage–mediated resistance pathway in anti–PD-1 therapy
- (2017) Sean P. Arlauckas et al. Science Translational Medicine
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
- (2016) J. M. Kim et al. ANNALS OF ONCOLOGY
- A lipid nanoparticle for the efficient delivery of siRNA to dendritic cells
- (2016) Shota Warashina et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination
- (2016) Yi-Nan Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Design, Synthesis, and Biological Evaluation of Novel Cyclic Adenosine–Inosine Monophosphate (cAIMP) Analogs That Activate Stimulator of Interferon Genes (STING)
- (2016) Thierry Lioux et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
- (2016) Olivier De Henau et al. NATURE
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Regulation and function of the cGAS–STING pathway of cytosolic DNA sensing
- (2016) Qi Chen et al. NATURE IMMUNOLOGY
- Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
- (2016) Takashi Nakamura et al. Scientific Reports
- Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
- (2015) Sonja Kleffel et al. CELL
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Liposomes loaded with a STING pathway ligand, cyclic di-GMP, enhance cancer immunotherapy against metastatic melanoma
- (2015) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle uptake: The phagocyte problem
- (2015) Heather Herd Gustafson et al. Nano Today
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- A new adjuvant delivery system ‘cyclic di-GMP/YSK05 liposome’ for cancer immunotherapy
- (2014) Hiroko Miyabe et al. JOURNAL OF CONTROLLED RELEASE
- The Spleen in Local and Systemic Regulation of Immunity
- (2013) Vincenzo Bronte et al. IMMUNITY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
- (2013) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles
- (2012) Z. Garcia et al. BLOOD
- A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo
- (2012) Yusuke Sato et al. JOURNAL OF CONTROLLED RELEASE
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA
- (2011) Federico Perche et al. Nanomedicine-Nanotechnology Biology and Medicine
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- The Liver as a Lymphoid Organ
- (2009) Ian Nicholas Crispe Annual Review of Immunology
- HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation
- (2008) Adriano Boasso et al. PLoS One
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started